Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Imaginostics is creating the next generation of precision medicine diagnostic and prognostic tools.
Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases.
Piccolo Medical is a medical device company.
Amptify is an ecosystem of hearing health built to improve the provider and patient experience through comprehensive tech-enhanced care.
Evon Medics, LLC is focused on developing and delivering breakthrough therapeutics and devices to address brain-related conditions.
Praetego is a pharmaceutical company focused on addressing serious diabetic complications.
Sonde Health is a digital medicine company.
EIP Pharma is a clinical stage therapeutics company developing drugs to treat neurodegenerative diseases.
VivoSense is an advancing clinical research with wearable sensor solutions.
This company is provides cutting edge analysis of brain images to enable disease diagnosis.
Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.
T3D Therapeutics is a company developing remedial therapeutics for Alzheimer’s disease and other CNS disorders.
Blue Marble Health is telehealth and remote therapeutic monitoring platform for aging and chronic disease management.
Tulane University Brain Institute focus on understanding why estrogen therapy helps protect some women from age-related brain problems.
The leading digital therapeutic and community for Alzheimer’s and cognitive health
Cleveland Alzheimer's Disease Research Center is the multi-institutional Alzheimer research center.
Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.
Rendever is a research-based virtual reality platform that provides cognitive stimulation, socialization, and therapy for older adults.
RevBio was started with one goal in mind—to end medicine’s 50-year search for a biocompatible bone adhesive.
ADvantage Therapeutics develops therapies to treat neurodegenerative conditions focusing on Alzheimer’s Disease.
BetterAge provides a personalized, web-based program to help individuals improve health and well-being.
SeeInMe develops a digital health platform designed to enhance person-centered coordinated care for care recipients.
Lighthouse Pharma's strategy combines translational insights with considerable clinical experience to understand and treat dementia.
Calder Biosciences is a groundbreaking biotechnology and molecular engineering firm developing next generation subunit vaccines
National Institute on Aging has invested in 67 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institute on Aging's top investment sectors include Health Care, Biotechnology, Medical, Therapeutics, Wellness. The firm invests across 29 different industry categories.
Among tracked funding rounds, Lighthouse Pharma received $49.2M in a Grant round. National Institute on Aging's total known invested capital is $362.5M.
National Institute on Aging's average investment size is $5.4M across its portfolio of 67 companies.
Recent National Institute on Aging portfolio additions include Imaginostics, Bolden Therapeutics, Piccolo Medical, Amptify, Evon Medics. These companies were founded in 2020 or later.